Press releaseBusiness Wire
Real Brokerage
REAX · NASDAQ
$15.94−$0.38 (−2.33%)TodayMarket closed ·
Prev close $16.32
About REAX
- Employees
- 474
- Headquarters
- Miami, British Columbia
- Listed
- Jun 23, 2004
- Sector
- Real Estate
- Industry
- Real Estate Management & Development
- Website
- onereal.ca
REAX key statistics
- Market cap
- 582.82M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 650.19K
- Volume
- 426.72K
- Open price
- $15.74
- High today
- $16.22
- Low today
- $15.59
- 52 Week high
- $45.00
- 52 Week low
- $13.25
Real Brokerage (REAX) at a glance
As of Oct 23, 2026, Real Brokerage (REAX) shares are priced at $15.94, giving the company a market cap of 582.82M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $15.59 and $16.22. The current price is 2.2% above the day's low and 1.7% below its high.
Volume so far is 426.72K shares, below the average of 650.19K shares a day.
Over the past year Real Brokerage has ranged from $13.25 to $45.00, and now sits 8% of the way up that range.
Real Brokerage met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.15 per share against an estimate of $0.068.
The average analyst price target is $46.75, 193.3% above the current price, from 8 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
75%of 8 analyst ratings say Buy
- Buy75.0%
- Hold25.0%
- Sell0.0%
Price target · 8 analystsAvg $46.75
- Low
- $35.35
- Now
- $15.94
- High
- $68.25
REAX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 90.2% on average.
- Q3 FY24: reported -$0.10 per share against an estimate of -$0.306
- Q4 FY24: reported -$0.30 per share against an estimate of -$0.459
- Q1 FY25: reported -$0.20 per share against an estimate of -$0.459
- Q2 FY25: reported $0.10 per share against an estimate of $0.0255
- Q3 FY25: reported $0.00 per share against an estimate of -$0.102
- Q4 FY25: reported -$0.20 per share against an estimate of -$0.3315
- Q1 FY26: reported -$0.20 per share against an estimate of -$0.2244
- Q2 FY26: reported $0.15 per share against an estimate of $0.068
REAX news
- Press releaseBusiness Wire
Real Introduces Leo Pro, the Next Generation of its AI Platform to Help Agents Handle Day-to-Day Work and Grow Their Businesses
- Press releaseBusiness Wire
Real REMAX Group to Host Third Quarter 2026 Earnings Conference Call
- Press releaseBusiness Wire
The Real Brokerage to Bring the Future of Real Estate to Life at RISE 2026
- Press releaseBusiness Wire
Joy and Robert Aumann Bring LUXURYSOCALREALTY to Real
- Press releasePRNewswire
Affordability Is Redefining Canadians' Path to Homeownership, According to REMAX
- Press releaseBusiness Wire
Real Launches Young Professionals Division to Build International Community for Next Generation of Real Estate Leaders
- Press releaseBusiness Wire
Real REMAX Group’s Monthly Agent Survey: Higher Mortgage Rates Deepen Affordability Pressures
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.